← Open Payments lookup

AQEEL HASHMI: Open Payments

NPI 1083900955 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,419 in 73 payments from 13 companies in 2025. Trend: 2023 $491 · 2024 $959 · 2025 $3,419

Food & beverage: $1,778Travel & lodging: $1,632Education: $10
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$2,185
E.R. Squibb & Sons, L.L.C.12$259
Janssen Pharmaceuticals, Inc4$171
Teva Pharmaceuticals USA, Inc.9$160
ABBVIE INC.9$155
Otsuka America Pharmaceutical, Inc.7$147
Alkermes, Inc.4$80
Axsome Therapeutics, Inc.4$77
Lundbeck LLC2$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49

Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII, AUSTEDO XR, ARISTADA, Auvelity.

Industry payments across TX — which companies pay providers there.